Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.500
-0.050 (-3.23%)
Nov 2, 2026, 4:30 PM CET
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 936.06 million as of November 2, 2026. It is the 25,115th most valuable company in the world and the 309th biggest in Sweden. Its market cap has increased by 1,445.40% in one year.
Market Cap
936.06M
Enterprise Value
687.06M
Revenue
8.71M
Global Rank
Country Rank
#309 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 30, 1999, Medivir AB's market cap has increased from 643.11M to 936.06M, an increase of 45.55%. That is a compound annual growth rate of 1.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 936.06M | 410.09% |
| Dec 30, 2025 | 183.51M | -42.39% |
| Dec 30, 2024 | 318.56M | 100.20% |
| Dec 29, 2023 | 159.12M | -71.16% |
| Dec 30, 2022 | 551.67M | -11.61% |
| Dec 30, 2021 | 624.11M | 209.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.51B |
| Genovis AB (publ.) | 1.46B |
| Flerie AB | 1.17B |
| SynAct Pharma AB | 881.41M |
| AlzeCure Pharma AB | 879.79M |
| Infant Bacterial Therapeutics AB | 864.87M |
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 569.95M |